参考文献/References:
[1]Jordan AS,McSharry DG,Malhotra A.Adult obstructive sleep apnoea[J].Lancet,2014,383(9918):736-747.[2]Senaratna CV,Perret JL,Lodge CJ,et al.Prevalence of obstructive sleep apnea in the general population:A systematic review [J].Sleep Medicine Reviews,2017,34:70-81.[3]Tasali E,Mokhlesi B,Van Cauter E.Obstructive sleep apnea and type 2 diabetes: interacting epidemics[J].Chest,2008,133(2):496-506.[4]Heffner JE,Rozenfeld Y,Kai M,et al.Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care[J].Chest,2012,141(6):1414-1421.[5]Kent BD,Grote L,Ryan S,et al.Diabetes mellitus prevalence and control in sleep-disordered breathing:the European Sleep Apnea Cohort (ESADA) study[J].Chest,2014,146(4):982-990.[6]Nannapaneni S,Ramar K,Surani S.Effect of obstructive sleep apnea on type 2 diabetes mellitus:A comprehensive literature review[J].World Journal of Diabetes,2013,4(6):238-244.[7]Ryan S.Adipose tissue inflammation by intermittent hypoxia:mechanistic link between obstructive sleep apnoea and metabolic dysfunction[J].The Journal of Physiology,2017,595(8):2423-2430.[8]Uchiyama T,Ota H,Ohbayashi C,et al.Effects of Intermittent Hypoxia on Cytokine Expression Involved in Insulin Resistance[J].International Journal of Molecular Sciences,2021,22(23):12898.[9]Zhang J,Tian L,Guo L.Changes of aldosterone levels in patients with type 2 diabetes complicated by moderate to severe obstructive sleep apnea-hypopnea syndrome before and after treatment with continuous positive airway pressure[J].J Int Med Res,219,7(10):4723-4733.[10]Semenza GL,Wang GL.A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation[J].Mol Cell Biol,1992,12(12):5447-5454.[11]Yu LM,Zhang WH,Han XX,et al.Hypoxia-Induced ROS Contribute to Myoblast Pyroptosis during Obstructive Sleep Apnea via the NF-κB/HIF-1α Signaling Pathway[J].Oxid Med Cell Longev,2019,2019:4596368.[12]Lu D,Li N,Yao X,et al.Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrome[J].Bosnian Journal of Basic Medical Sciences,2017,17(1):47-53.[13]Gabryelska A,Stawski R,Sochal M,et al.Influence of one-night CPAP therapy on the changes of HIF-1α protein in OSA patients:A pilot study[J].Journal of Sleep Research,2020,29(4):e12995.[14]Ota H,Fujita Y,Yamauchi M,et al.Relationship Between Intermittent Hypoxia and Type 2 Diabetes in Sleep Apnea Syndrome[J].International Journal of Molecular Sciences,2019,20(19):4756.[15]Gabryelska A,Karuga FF,Szmyd B,et al.HIF-1α as a Mediator of Insulin Resistance,T2DM,and Its Complications:Potential Links With Obstructive Sleep Apnea[J].Frontiers in Physiology,2020,11:1035.[16]Nagao A,Kobayashi M,Koyasu S,et al.HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance[J].International Journal of Molecular Sciences,2019,20(2):238.[17]Kim JW,Tchernyshyov I,Semenza GL,et al.HIF-1-mediated expression of pyruvate dehydrogenase kinase:a metabolic switch required for cellular adaptation to hypoxia[J].Cell Metabolism,2006,3(3):177-185.[18]Gaster M,Nehlin JO,Minet AD.Impaired TCA cycle flux in mitochondria in skeletal muscle from type 2 diabetic subjects:marker or maker of the diabetic phenotype?[J].Archives of Physiology and Biochemistry,2012,118(3):156-189.[19]Guasch-ferré M,Santos JL,Martínez-González MA,et al.Glycolysis/gluconeogenesis- and tricarboxylic acid cycle-related metabolites,Mediterranean diet,and type 2 diabetes[J].The American Journal of Clinical Nutrition,2020,111(4):835-844.[20]Choi CS,Kim YB,Lee FN,et al.Lactate induces insulin resistance in skeletal muscle by suppressing glycolysis and impairing insulin signaling[J].American Journal of Physiology Endocrinology and Metabolism,2002,283(2):E233-E240.[21]Ahmed K,Tunaru S,Tang C,et al.An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81[J].Cell Metabolism,2010,11(4):311-319.[22]Wang N,Shi X F,Khan SA,et al.Hypoxia-inducible factor-1 mediates pancreatic β-cell dysfunction by intermittent hypoxia[J].American Journal of Physiology Cell Physiology,2020,319(5):C922-C932.[23]Wang N,Khan SA,Prabhakar NR,et al.Impairment of pancreatic β-cell function by chronic intermittent hypoxia[J].Experimental Physiology,2013,98(9):1376-1385.[24]Sacramento JF,Ribeiro MJ,Rodrigues T,et al.Insulin resistance is associated with tissue-specific regulation of HIF-1α and HIF-2α during mild chronic intermittent hypoxia[J].Respir Physiol Neurobiol,2016,228:30-38.[25]Kihira Y,Miyake M,Hirata M,et al.Deletion of hypoxia-inducible factor-1α in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue inflammation[J].PLoS One,2014,9(4):e93856.[26]Lee YS,Kim JW,Osborne O,et al.Increased adipocyte O2 consumption triggers HIF-1α,causing inflammation and insulin resistance in obesity[J].Cell,2014,157(6):1339-1352.[27]Cildir G,Ak?覦nc?覦lar SC,Tergaonkar V.Chronic adipose tissue inflammation:all immune cells on the stage[J].Trends in Molecular Medicine,2013,19(8):487-500.[28]Rabe K,Lehrke M,Parhofer KG,et al.Adipokines and insulin resistance[J].Molecular medicine (Cambridge,Mass),2008,14(11-12):741-751.[29]Odegaard JI,Chawl AA.Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis[J].Science (New York,NY),2013,339(6116):172-177.[30]Takeda N,O’dea EL,Doedens A,et al.Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis[J].Genes&Development,2010,24(5):491-501.[31]Yasukawa T,Tokunaga E,Ota H,et al.S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance[J].The Journal of Biological Chemistry,2005,280(9):7511-7518.[32]Yazdanpanah L,Nasiri M,Adarvishi S.Literature review on the management of diabetic foot ulcer[J].World Journal of Diabetes,2015,6(1):37-53.[33]Catrina SB,Zheng X.Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers[J].Diabetes/Metabolism Research and Reviews,2016,32 Suppl 1:179-185.[34]Thangarajah H,Vial IN,Grogan RH,et al.HIF-1alpha dysfunction in diabetes[J].Cell Cycle (Georgetown,Tex),2010,9(1):75-79.[35]Guo C,Hao LJ,Yang ZH,et al.Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice[J].Experimental Neurology,2016,280:13-23.[36]Wang W,Lo ACY.Diabetic Retinopathy: Pathophysiology and Treatments[J].Int J Mol Sci,2018,19(6):1816.[37]Rosenberger C,Khamaisi M,Abassi Z,et al.Adaptation to hypoxia in the diabetic rat kidney[J].Kidney International,2008,73(1):34-42.[38]Bessho R,Takiyama Y,Takiyama T,et al.Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy[J].Scientific Reports,2019,9(1):14754.[39]Li Q,Liu Y,Xia X,et al.Activation of macrophage TBK1-HIF-1α-mediated IL-17/IL-10 signaling by hyperglycemia aggravates the complexity of coronary atherosclerosis:An in vivo and in vitro study[J].FASEB J,2021,35(5):e21609.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(01):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(01):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(01):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(01):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(01):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]邹海涛,李永霞.普通人群及医务人员OSAHS认知现状及
相关因素的研究进展[J].医学信息,2018,31(14):24.[doi:10.3969/j.issn.1006-1959.2018.14.009]
ZOU Hai-tao,LI Yong-xia.Research Progress of OSAHS Cognition Status and Related Factors among General Population and Medical Staff[J].Journal of Medical Information,2018,31(01):24.[doi:10.3969/j.issn.1006-1959.2018.14.009]
[7]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行
健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(01):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[8]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Journal of Medical Information,2018,31(01):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
[9]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(01):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[10]刘小红.长效胰岛素联合口服降糖药治疗2型糖尿病的
疗效与安全性评价[J].医学信息,2018,31(18):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
LIU Xiao-hong.Efficacy and Safety of Long Acting Insulin Combined with Oral Hypoglycemic Agents in Treatment of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(01):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]